Dr. Ahmed Al-Sabi earned undergraduate and master's degrees in biological sciences and marine biology from Yarmouk University in Jordan.
The Max-Planck Institute for Experimental Medicine in Göttingen (Germany) has awarded him a scholarship to study a novel Conus radiatus-derived peptide blocker of neuronal voltage-gated potassium channels for his Ph.D. This study revealed a novel channelopathy-targeting neurotherapeutic pharmacophore using structural and functional data. His nearly ten years of post-doctoral neurophysiology research at the University of Calgary (Canada) and Dublin City University (Ireland) gave him a comprehensive understanding of voltage-gated potassium and sodium channels, and their effects on disease states. His research focused on marine and terrestrial neurotoxins to develop synthetic compounds selective against channelopathies and demyelinated neurons. Collaborative research contributed to fundamental neuroscience through peer-reviewed journals and proceedings worldwide. He is a member of several international societies and reviews articles for journals. For 14 years, he has won awards for teaching various courses at the graduate and undergraduate levels. He guest edited Frontiers of Physiology and npj Drug Discovery special issues.
Dr. Ahmed Al-Sabi is currently an Associate Professor at Abdullah Al Salem University in Kuwait, where he is pursuing additional academic and research endeavours in the field of neurophysiology.
Dr. Ahmed Al-Sabi earned undergraduate and master's degrees in biological sciences and marine biology from Yarmouk University in Jordan.
The Max-Planck Institute for Experimental Medicine in Göttingen (Germany) has awarded him a scholarship to study a novel Conus radiatus-derived peptide blocker of neuronal voltage-gated potassium channels for his Ph.D. This study revealed a novel channelopathy-targeting neurotherapeutic pharmacophore using structural and functional data. His nearly ten years of post-doctoral neurophysiology research at the University of Calgary (Canada) and Dublin City University (Ireland) gave him a comprehensive understanding of voltage-gated potassium and sodium channels, and their effects on disease states. His research focused on marine and terrestrial neurotoxins to develop synthetic compounds selective against channelopathies and demyelinated neurons. Collaborative research contributed to fundamental neuroscience through peer-reviewed journals and proceedings worldwide. He is a member of several international societies and reviews articles for journals. For 14 years, he has won awards for teaching various courses at the graduate and undergraduate levels. He guest edited Frontiers of Physiology and npj Drug Discovery special issues.
Dr. Ahmed Al-Sabi is currently an Associate Professor at Abdullah Al Salem University in Kuwait, where he is pursuing additional academic and research endeavours in the field of neurophysiology.